Patents

US 12753419 B2: Compositions useful for treatment of Charcot-Marie-Tooth disease

Granted
2026-10-06
Filed
2022-09-23 application 18694823
Type
Utility · 22 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Provided herein are rAAV and other vectors and compositions useful for treating a patient having CMT2 comprising: (a) a recombinant nucleic acid sequence encoding an engineered human mitofusin 2 coding sequence operably linked to regulatory sequences which direct expression thereof in a human target cell. Also provided are rAAV and other vectors and compositions useful for treating a patient having CMT2 comprising: (b) a nucleic acid sequence encoding at least one miRNA specific for an endogenous human mitofusin 2 sequence in a human CMT2A subject, wherein the miRNA coding sequence is operably linked to regulatory sequences which direct expression thereof in the subject. Further provided are compositions containing both the engineered hMfn2 coding sequence and the at least one miRNA coding sequence, wherein the engineered human mitofusin 2 coding sequence has a sequence which differs from endogenous human mitofusin 2 in the CMT2A patient in the target site of the encoded miRNA.

Source: PTBLXML, file of 2026-10-06 (ipgb20261006.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
The Trustees of the University of Pennsylvania 1,699 patentsUS company or organizationPhiladelphia, PAUniversity of Pennsylvania College or university FUZZY medium confidence: same name (governing-board words and legal endings aside) and state
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA Nonprofit FUZZY medium confidence: same name (governing-board words and legal endings aside) and state
PTBLXML, file of 2026-10-06

Inventors

InventorPlacePatentsPerson pageSource
James M. WilsonPhiladelphia, PA137PTBLXML, file of 2026-10-06
Christian HindererBaltimore, MD19PTBLXML, file of 2026-10-06
Eileen WorkmanPhiladelphia, PAPTBLXML, file of 2026-10-06

CPC categories

SubclassCategoryFirst groupSource
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N15/86PTBLXML, file of 2026-10-06
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P25/02PTBLXML, file of 2026-10-06

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.